These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
387 related items for PubMed ID: 19356748
21. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease. Kwak Y, Müller ML, Bohnen NI, Dayalu P, Seidler RD. Behav Brain Res; 2012 Apr 21; 230(1):116-24. PubMed ID: 22343069 [Abstract] [Full Text] [Related]
22. The basal ganglia and semantic engagement: potential insights from semantic priming in individuals with subcortical vascular lesions, Parkinson's disease, and cortical lesions. Copland D. J Int Neuropsychol Soc; 2003 Nov 21; 9(7):1041-52. PubMed ID: 14738285 [Abstract] [Full Text] [Related]
23. Pain intensity on and off levodopa in patients with Parkinson's disease. Nebe A, Ebersbach G. Mov Disord; 2009 Jun 15; 24(8):1233-7. PubMed ID: 19412949 [Abstract] [Full Text] [Related]
24. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease. Shohamy D, Myers CE, Grossman S, Sage J, Gluck MA. Behav Brain Res; 2005 Jan 30; 156(2):191-9. PubMed ID: 15582105 [Abstract] [Full Text] [Related]
29. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease. Herzog J, Möller B, Witt K, Pinsker MO, Deuschl G, Volkmann J. Mov Disord; 2009 Jun 15; 24(8):1206-10. PubMed ID: 19412937 [Abstract] [Full Text] [Related]
31. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory. Costa A, Peppe A, Dell'Agnello G, Caltagirone C, Carlesimo GA. Neuropsychologia; 2009 Apr 15; 47(5):1374-81. PubMed ID: 19428401 [Abstract] [Full Text] [Related]
32. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease. De Letter M, Santens P, De Bodt M, Van Maele G, Van Borsel J, Boon P. Clin Neurol Neurosurg; 2007 Jul 15; 109(6):495-500. PubMed ID: 17509751 [Abstract] [Full Text] [Related]
33. Brain dopaminergic modulation associated with executive function in Parkinson's disease. Farid K, Sibon I, Guehl D, Cuny E, Burbaud P, Allard M. Mov Disord; 2009 Oct 15; 24(13):1962-9. PubMed ID: 19672989 [Abstract] [Full Text] [Related]
36. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing. Mongeon D, Blanchet P, Messier J. Neuroscience; 2009 Jan 23; 158(2):426-40. PubMed ID: 18996173 [Abstract] [Full Text] [Related]
38. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia. Zoccolella S, dell'Aquila C, Abruzzese G, Antonini A, Bonuccelli U, Canesi M, Cristina S, Marchese R, Pacchetti C, Zagaglia R, Logroscino G, Defazio G, Lamberti P, Livrea P. Mov Disord; 2009 May 15; 24(7):1028-33. PubMed ID: 19353704 [Abstract] [Full Text] [Related]
39. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation. Rodrigues JP, Walters SE, Stell R, Mastaglia FL, Thickbroom GW. Neurosci Lett; 2008 Dec 19; 448(1):29-32. PubMed ID: 18952149 [Abstract] [Full Text] [Related]
40. Quantitative study of salivary secretion in Parkinson's disease. Tumilasci OR, Cersósimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH. Mov Disord; 2006 May 19; 21(5):660-7. PubMed ID: 16419045 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]